3231 - 3240 of 8142 Results
Title
Year
-
OPENTitle: Computational medication regimen for Parkinson’s disease using reinforcement learningJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88619-4Best OA location URL: https://www.nature.com/articles/s41598-021-88619-4.pdfCitation Count: 22
- Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson's disease2021RESTRICTEDTitle: Feature selection and machine learning methods for optimal identification and prediction of subtypes in Parkinson's diseaseJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 206Issue #:Start Page: 106131End Page: 106131Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cmpb.2021.106131Citation Count: 34
- Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages2021OPENTitle: Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stagesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-88877-2Best OA location URL: https://www.nature.com/articles/s41598-021-88877-2.pdfCitation Count: 23
- Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s disease2021RESTRICTEDTitle: Towards physiologically relevant human pluripotent stem cell (hPSC) models of Parkinson’s diseaseJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-021-02326-5Best OA location URL: https://stemcellres.biomedcentral.com/track/pdf/10.1186/s13287-021-02326-5Citation Count: 9
- An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia2021OPENTitle: An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical DystoniaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 743End Page: 749Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13229Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13229Citation Count: 8
-
OPENTitle: Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy BrainsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2021.652226Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2021.652226/pdfCitation Count: 14
- Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS Study2021OPENTitle: Concomitant Medication Usage with Levodopa‐Carbidopa Intestinal Gel: Results from the COSMOS StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1853End Page: 1862Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28596Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28596Citation Count: 33
- Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients2021OPENTitle: Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 25End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.012Best OA location URL: http://www.prd-journal.com/article/S1353802021001450/pdfCitation Count: 17
- Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias2021OPENTitle: Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic ParaplegiasJournal Name: iSciencePublisher: Elsevier BVVol: 24Issue #: 5Start Page: 102484End Page: 102484Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2021.102484Best OA location URL: http://www.cell.com/article/S2589004221004521/pdfCitation Count: 9
- Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and Projections2021OPENTitle: Measuring Patient Preferences at the FDA Center for Devices and Radiological Health: Reflections and ProjectionsJournal Name: Value in HealthPublisher: Elsevier BVVol: 24Issue #: 7Start Page: 1024End Page: 1029Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jval.2021.01.009Best OA location URL: http://www.valueinhealthjournal.com/article/S109830152100139X/pdfCitation Count: 3